{"name": "Amylin Pharmaceuticals",
 "permalink": "amylin-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/amylin-pharmaceuticals",
 "homepage_url": "http://www.amylin.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": 1900,
 "founded_year": 1987,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": null,
 "alias_list": "",
 "email_address": "corporateaffairsmail@amylin.com",
 "phone_number": "858-552-2200",
 "description": "biotechnology company",
 "created_at": "Fri Sep 18 07:17:44 UTC 2009",
 "updated_at": "Thu Mar 29 04:37:21 UTC 2012",
 "overview": "\u003Cp\u003EWorking towards a cure for diabetes by challenging science, changing lives. Amylin employees are dedicated in their ability to \u0026#8220;think outside the box\u0026#8221;. Because of our commitment of constantly finding newer and better ways to treat diabetes, we come to work each day feeling like we CAN make a difference in our world.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[142,
       63],
      "assets/images/resized/0006/0118/60118v1-max-150x150.png"],
     [[142,
       63],
      "assets/images/resized/0006/0118/60118v1-max-250x250.png"],
     [[142,
       63],
      "assets/images/resized/0006/0118/60118v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Vice President, Corporate Development",
    "person":
     {"first_name": "Micheal",
      "last_name": "Step",
      "permalink": "micheal-step",
      "image":
       {"available_sizes":
         [[[139,
            138],
           "assets/images/resized/0025/4493/254493v1-max-150x150.jpg"],
          [[139,
            138],
           "assets/images/resized/0025/4493/254493v1-max-250x250.jpg"],
          [[139,
            138],
           "assets/images/resized/0025/4493/254493v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Senior Vice President, Research \u0026 Development",
    "person":
     {"first_name": "Christian",
      "last_name": "Weyer",
      "permalink": "christian-weyer",
      "image":
       {"available_sizes":
         [[[122,
            150],
           "assets/images/resized/0026/4805/264805v1-max-150x150.png"],
          [[157,
            192],
           "assets/images/resized/0026/4805/264805v1-max-250x250.png"],
          [[157,
            192],
           "assets/images/resized/0026/4805/264805v1-max-450x450.png"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "Chairman",
    "person":
     {"first_name": "Howard",
      "last_name": "(Ted) Greene, Jr.",
      "permalink": "howard-ted-greene-jr",
      "image": null}},
   {"is_past": true,
    "title": "Leadership Positions In Clinical \u0026 Medical Affairs",
    "person":
     {"first_name": "Juan",
      "last_name": "P. Frias",
      "permalink": "juan-p-frias",
      "image": null}},
   {"is_past": true,
    "title": "Senior Director of Marketing, BYETTA \u0026 BYDUREON",
    "person":
     {"first_name": "Mark",
      "last_name": "Mahmood",
      "permalink": "mark-mahmood",
      "image":
       {"available_sizes":
         [[[150,
            150],
           "assets/images/resized/0026/6872/266872v1-max-150x150.jpg"],
          [[200,
            200],
           "assets/images/resized/0026/6872/266872v1-max-250x250.jpg"],
          [[200,
            200],
           "assets/images/resized/0026/6872/266872v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "Board Member",
    "person":
     {"first_name": "Karin",
      "last_name": "Eastham",
      "permalink": "karin-eastham",
      "image":
       {"available_sizes":
         [[[109,
            150],
           "assets/images/resized/0026/4129/264129v1-max-150x150.jpg"],
          [[128,
            176],
           "assets/images/resized/0026/4129/264129v1-max-250x250.jpg"],
          [[128,
            176],
           "assets/images/resized/0026/4129/264129v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [{"funding_round":
     {"round_code": "c",
      "source_url": "http://venturebeat.com/2007/05/23/bioseek-raises-10m-from-amylin-pharmafor-drug-screening/",
      "source_description": "BioSeek raises $10M from Amylin Pharma for drug screening",
      "raised_amount": 10000000.0,
      "raised_currency_code": "USD",
      "funded_year": 2007,
      "funded_month": 5,
      "funded_day": 23,
      "company":
       {"name": "BioSeek",
        "permalink": "bioseek",
        "image":
         {"available_sizes":
           [[[98,
              38],
             "assets/images/resized/0006/0117/60117v1-max-150x150.jpg"],
            [[98,
              38],
             "assets/images/resized/0006/0117/60117v1-max-250x250.jpg"],
            [[98,
              38],
             "assets/images/resized/0006/0117/60117v1-max-450x450.jpg"]],
          "attribution": null}}}},
   {"funding_round":
     {"round_code": "unattributed",
      "source_url": "http://www.xenome.com/v2/index.php?menu=news_full\u0026id=52\u0026year=news_2007",
      "source_description": "Xenome Receives a syndicated US$10 Million Equity Investment from Queensland BioCapital Fund, Amylin Pharmaceuticals and Innovis Investment  Partners.",
      "raised_amount": 10000000.0,
      "raised_currency_code": "USD",
      "funded_year": 2007,
      "funded_month": 11,
      "funded_day": 27,
      "company":
       {"name": "Xenome",
        "permalink": "xenome",
        "image":
         {"available_sizes":
           [[[150,
              65],
             "assets/images/resized/0008/0338/80338v1-max-150x150.jpg"],
            [[206,
              90],
             "assets/images/resized/0008/0338/80338v1-max-250x250.jpg"],
            [[206,
              90],
             "assets/images/resized/0008/0338/80338v1-max-450x450.jpg"]],
          "attribution": null}}}}],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "HQ",
    "address1": "9360 Towne Centre Drive",
    "address2": "",
    "zip_code": "92121",
    "city": "San Diego",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "UPDATED: Amylin shares rocket up on report of $3.5B buyout offer by Bristol-Myers",
    "stoned_year": 2012,
    "stoned_month": 3,
    "stoned_day": 28,
    "source_url": "http://www.fiercebiotech.com/story/amylin-shares-rocket-report-35b-buyout-offer-bristol-myers/2012-03-28?utm_medium=rss\u0026utm_source=rss",
    "source_text": "",
    "source_description": "UPDATED: Amylin shares rocket up on report of $3.5B buyout offer by Bristol-Myers",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Amylin Pharmaceuticals",
      "permalink": "amylin-pharmaceuticals"}}],
 "ipo":
  {"valuation_amount": null,
   "valuation_currency_code": "USD",
   "pub_year": null,
   "pub_month": null,
   "pub_day": null,
   "stock_symbol": "NASDAQ:AMLN"},
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}